医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Foxconn Selects Wisconsin with Commitment to High-Tech Manufacturing

2017年07月27日 AM07:32
このエントリーをはてなブックマークに追加


 

MADISON, Wis.

Foxconn Technology Group (Foxconn), has announced this afternoon that the company will be building a high-tech display manufacturing plant and technology campus in Southeastern Wisconsin. The 8K liquid crystal display (LCD) screens manufactured at the campus will enable new medical solutions for surgical procedures and has the potential to reduce the cost of healthcare.

“BioForward and Wisconsin’s biohealth community welcomes Foxconn to the state and looks forward to opportunities for collaboration,” said Lisa Johnson, CEO of BioForward Wisconsin. “Attracting a technology leader such as Foxconn will benefit Wisconsin in numerous ways from high-tech job opportunities, industry collaborations, and benefiting Wisconsin’s extensive state-wide supply chain.”

Wisconsin’s biohealth industry also relies heavily on high-tech manufacturers throughout the state. Amongst several notable international investments in Wisconsin, attracting Foxconn to the state further showcases Wisconsin as a technology and manufacturing leader.

Foxconn Technology Group is a multi-dimensional company with not only a focus in manufacturing, but also a large healthcare division. Terry Gou, Chairman of Foxconn, has demonstrated his commitment to advancing healthcare with large investments in Taipei’s Cancer Center and providing major funding to medical research.

With Foxconn’s decision to invest in Wisconsin for display manufacturing comes the possibility of research partnerships, high-tech healthcare manufacturing, and employment for Wisconsin’s concentration of STEM-educated workforce. Foxconn has a history of investments in high-tech healthcare and technology initiatives. The state of Wisconsin presents additional opportunities for partnership in similar initiatives such as Wisconsin’s Biomanufacturing Center of Excellence.

“We’re thrilled Foxconn has chosen Wisconsin for the 8K display manufacturing plant and technology campus, and we’re excited to develop this relationship with Foxconn to further support their interest in healthcare as part of their U.S. expansion strategy,” said Lisa Johnson.

For more information and formal statements, please contact Lisa Johnson at (608)-236-4753, or email ljohnson@bioforward.org.

About BioForward Wisconsin

BioForward serves as the independent voice of Wisconsin’s biohealth industry, providing services and resources to support the growth of our industry throughout the U.S. and the world. BioForward is the only Wisconsin organization representing over 200 biohealth member companies including biotech, biopharma, medical device, diagnostics, digital health, as well as research institutions, and service providers. Our focus in 2017 is advocating on behalf of Wisconsin’s industry strength in integrated health solutions and research. We have implemented a Strength of Wisconsin Biohealth campaign and placed emphasis that BioForward represents this impactful industry for the state of Wisconsin.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170726006467/en/

CONTACT

Lisa Johnson
CEO, BioForward Wisconsin
Phone: (608)-236-4753
Email:
ljohnson@bioforward.org
Website:
http://www.bioforward.org/

同じカテゴリーの記事 

  • BostonGene and Saga University Announce Collaboration to Uncover Biomarkers for Improved Immunotherapy Response in Lung Cancer Patients
  • MRMヘルス、回腸嚢炎治療薬MH002の第2a相臨床試験で安全性と良好な有効性データを報告
  • KBIバイオファーマ、Jean-Baptiste Agnus氏を最高業務責任者(CBO)に指名
  • 佐賀大学とBostonGeneがEGFR陽性肺癌患者におけるICIの治療効果予測因子を特定するための新規バイオマーカー探索を目的とした研究を発表
  • KBI Biopharma任命Jean-Baptiste Agnus为首席商务官